Global Rheumatic Fever Treatment Market Overview
Rheumatic fever is an infectious inflammatory condition that can occur as a result of strep throat that hasn't been properly handled. Rheumatic Fever Treatment Market can cause long-term damage to the heart and heart valves in some people. It develops as a result of group A streptococcal pharyngitis that takes a long time to resolve. It may affect the joints, heart, blood vessels, and skin's connective tissues. Rheumatic fever is a leading cause of death in people over the age of 50. When compared to younger people, people aged 50 and up have a higher prevalence of rheumatic disease and a higher mortality rate. Rheumatic fever is one of the most common causes of disability.
Impact of Covid-19 pandemic on market
The risk of severe illness, complications, or death for people with rheumatic disease was unclear as the COVID-19 pandemic spread around the world in early 2020. Early research also indicated that these drugs could have a protective impact, but questions about patient vulnerability persisted. In people with rheumatic diseases, the COVID-19 infection rate is low, and the majority of those infected have a mild illness.
Global Rheumatic Fever Treatment Market Dynamics
Growth in business operations by emerging and small sized players
Growing strep throat cases and the rising prevalence of rheumatic heart disease are expected to be the primary drivers of market growth over the forecast period. Over the forecast period, a lack of knowledge about rheumatic fever, especially in developing countries, is likely to be a major impediment to the global rheumatic fever market. The lack of healthcare facilities in developed countries is also a significant business constraint. Furthermore, increased government spending in the healthcare sector aids business expansion. When compared to developed countries, the incidence rate of rheumatic fever is higher in developing countries.
Global Rheumatic Fever Treatment Market Segmentation
Source: Prophecy Market Insights
Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.
The Rheumatic Fever treatment market is segmented based on drug class, distribution channel, route of administration, end-user and region.
On the basis of drug class, the Rheumatic fever treatment market is segmented into antibiotics, disease modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs, anticonvulsant medication and others. Based on distribution channel, the target market is segmented into hospitals pharmacies, online pharmacies & retail pharmacies. On the basis of route of administration, the target market is segmented into oral, parenteral and topical.
Regional Insights:
On region the Rheumatic Fever Treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Due to a well-developed healthcare system, the prevalence of cardiovascular diseases, and rising healthcare expenditure, North America is expected to dominate the global rheumatic fever market. Due to the existence of a large patient population, rapidly evolving economies, rising incidents of rheumatic fever, and increasing government funding for the healthcare sector, Asia-Pacific is expected to be the fastest growing area in the industry.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Drug Class- Antibiotics, Disease Modifying Anti-Rheumatic Drugs, Non-Steroidal Anti-Inflammatory Drugs, Anticonvulsant Medication And Others. By Distribution Channel– Hospitals Pharmacies, Online Pharmacies And Retail Pharmacies. By Route Of Administration– Oral, Parenteral And Topical. |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2030. For the purpose of this study, has segmented the rheumatic fever market report based on drug class, distribution channel, route of administration end-use, and region.
Rheumatic Fever Treatment Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Rheumatic Fever Treatment Market Key Players
The key players operating in the global rheumatic fever market includes Abbott, F. Hoffmann-La Roche Ltd, Novartis, Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Bayer AG, and Bausch Health Companies Inc.
Global Rheumatic Fever Treatment Market Company Profile
- Abbott laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- F.Hoffmann-La Roche ltd
- Novartis
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca, Bayer AG
- Bausch Health Companies Inc.
“*” marked represents similar segmentation in other categories in the respective section
Global Rheumatic Fever Treatment Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Rheumatic Fever Treatment Strategies
- Key Questions this Study will Answer
- Market Snippet, By Drug class
- Market Snippet, By Distribution channel
- Market Snippet, By Route of administration
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Rheumatic Fever Treatment Market, By Drug class, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Antibiotics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Disease modifying anti-rheumatic drugs
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Non-steroidal anti-inflammatory drugs
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Anticonvulsant medication
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Rheumatic Fever Treatment Market, By Distribution channel, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospital pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Online pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Retail pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Rheumatic Fever Treatment Market, By Route of administration, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Oral
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Parenteral
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Topical
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Rheumatic Fever Treatment Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Abbott laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- F.Hoffmann-La Roche ltd
- Novartis
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca, Bayer AG
- Bausch Health Companies Inc.
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
The Rheumatic Fever treatment market is segmented based on drug class, distribution channel, route of administration end-use, and region.
Growing strep throat cases and the rising prevalence of rheumatic heart disease are expected to be the primary drivers of market growth over the forecast period.
Due to a well-developed healthcare system, the prevalence of cardiovascular diseases, and rising healthcare expenditure, North America is expected to dominate the global rheumatic fever market.
Companies are continuously rising the production and supply of drug. Abbott laboratories and Novartis are some of the major key players in the rheumatic fever treatment market.